Susquehanna Upgrades Lev Pharmaceuticals, Inc. (NasdaqL LEVP) to Positive with a $2.75 price target.

The firm said, "Based on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE